Risk Of Developing Liver Cancer After HCV Treatment

Tuesday, April 7, 2015

Pricing of Drugs and Formulary Placement: Making Sense of Hepatitis C Treatment

Pricing of Drugs and Formulary Placement: Making Sense of Hepatitis C Treatment
The webinar took place on Tuesday, March 31, 2015.
View the complete program, here.

Overview
Assessment of Needs
The IAS–USA offers this state-of-the-art activity as part of a nationwide CME effort for physicians on the evolving challenges of managing hepatitis C virus. This webinar will explore how insurance companies determine access to hepatitis C regimens, and what clinicians can do to help ensure that the best decisions are being made for people living with hepatitis C.

No comments:

Post a Comment